About this event

  • Date and time Mon 17 Mar 2025 from 9:15am to 4:30pm
  • Location Royal Society of Medicine
  • Organised by Radiology

With changing practices driven by advances in technology, tracers and drug development, it is important to keep up to date with the evolving role of PET (Positron Emission Tomography) and how it can affect clinical pathways as well as research.

Join us for this annual meeting to explore the latest innovations in PET-CT technology. Discover how advancements in tracers and drug development are transforming dementia imaging, particularly with the emergence of disease-modifying treatments. Additionally, delve into the evolving role of PET-CT in prostate cancer imaging and cutting-edge cardiovascular research.

By attending, you will:

  • Learn how total body PET-CT is changing clinical pathways and advancing research
  • Gain a better understanding of the use and effects of disease-modifying drugs in Alzheimer’s disease and how they can impact patients and affect PET pathways
  • Understand the impact of PSMA PET CT imaging in the staging of prostate cancer
  • Gain a better understanding of the advances in cardiovascular PET research

Follow us on: 

Facebook 
Instagram 
LinkedIn 
Twitter 
YouTube 

Tickets

Early Bird pricing available until 03 February 2025.

Member

RSM Fellow RSM Associate RSM Retired Fellow RSM Trainee RSM Student
£50.00 £30.00 £30.00 £30.00 £10.00

Non - Member

Consultant / GP / SAS Doctors AHP / Nurse / Midwife Trainee Student
£95.00 £50.00 £50.00 £30.00

Agenda

View the programme 17 March 2025

Registration, tea and coffee
Welcome and introduction

Dr George Petrides, Radiology Consultant, Newcastle Upon Tyne Hospitals

Session 1: Prostate cancer PET imaging

PSMA in the staging of prostate cancer: Radiologist and Urologist perspectives

Professor Tara Barwick, Consultant in Radiology and Nuclear Medicine, Imperial College London and Mr Martin Connor, Urologist and Academic Clinical Lecturer, Imperial College London

Title to be confirmed

Speaker to be confirmed

Panel discussion
Tea and coffee break

Session 2: Dementia

Clinical approaches to diagnosing Alzheimer's disease and the role of biomarkers in disease modifying therapies

Dr Bob Barber, Consultant Old Age Psychiatrist and Honorary Clinical Senior Lecturer, Newcastle

Setting up an amyloid PET service

Professor Vineet Prakash, Consultant In Nuclear Medicine, Royal Surrey County Hospital

Novel PET tracers for dementia

Professor John O’Brien, Professor of Old Age Psychiatry, University of Cambridge

Panel discussion
Lunch

Session 3: Cardiovascular imaging

PET in cardiovascular research

Professor Michelle Williams, Professor of Cardiovascular Imaging, University of Edinburgh

Title to be confirmed

Speaker to be confirmed

Panel discussion
Tea and coffee break

Session 4: Total body PET-CT

Total body PET-CT: A clinical perspective

Dr Thomas Wagner, Consultant in Nuclear Medicine, Royal Free Hospital London

Total body PET-CT: A research perspective

Professor Gary Cook, Professor of PET Imaging, King’s College London

Title to be confirmed

Speaker to be confirmed

Panel discussion

Dr Amy Eccles, Professor Gary Cook, Dr Thomas Wagner and Professor Michelle Williams 

Close of meeting

Location

Royal Society of Medicine, 1 Wimpole St, Marylebone, London, W1G 0AE, United Kingdom

Registrations will close on 16 March 2025 at 1:00am (GMT). Late registrations will not be accepted.

The agenda is subject to change at any time

If the event is recorded, we are only able to share presentations that we have received permission to share. There is no guarantee that all sessions will be available after the event, this is at the presenter’s and RSM’s discretion.

All views expressed at this event are of the speakers themselves and not of the Royal Society of Medicine, nor the speaker's organisations.

This event will be recorded and stored by the Royal Society of Medicine and may be distributed in future on various internet channels.